Intra-Cellular Therapies, Inc. (ITCI)
131.87
0.00 (0.00%)
Inactive · Last trade price on Apr 1, 2025
Intra-Cellular Therapies Employees
Intra-Cellular Therapies had 860 employees as of December 31, 2024. The number of employees increased by 250 or 40.98% compared to the previous year.
Employees
860
Change (1Y)
250
Growth (1Y)
40.98%
Revenue / Employee
$791,688
Profits / Employee
-$86,833
Market Cap
14.02B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 860 | 250 | 40.98% |
| Dec 31, 2023 | 610 | 49 | 8.73% |
| Dec 31, 2022 | 561 | 49 | 9.57% |
| Dec 31, 2021 | 512 | 129 | 33.68% |
| Dec 31, 2020 | 383 | 53 | 16.06% |
| Dec 31, 2019 | 330 | 257 | 352.05% |
| Dec 31, 2018 | 73 | 24 | 48.98% |
| Dec 31, 2017 | 49 | 7 | 16.67% |
| Dec 31, 2016 | 42 | 3 | 7.69% |
| Dec 31, 2015 | 39 | 13 | 50.00% |
| Dec 31, 2014 | 26 | 4 | 18.18% |
| Mar 31, 2013 | 22 | - | - |
ITCI News
- 1 year ago - Phathom Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 1 year ago - INTRA-CELLULAR THERAPIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Intra-Cellular Therapies, Inc. - ITCI - Business Wire
- 1 year ago - Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2024 Financial Results - GlobeNewsWire
- 1 year ago - Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last? - CNBC
- 1 year ago - SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN and ITCI on Behalf of Shareholders - PRNewsWire
- 1 year ago - Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal - WSJ
- 1 year ago - Drugmakers rush to sign deals on first day of industry conference - Reuters
- 1 year ago - Intra-Cellular Therapies Stock Pops as Johnson & Johnson Buys Firm for $14.6B - Investopedia